BNB PLUS CORP. (BNBX): Nasdaq/NYSE listing notice — Applied DNA Sciences receives Nasdaq delisting notice for bid price deficiency; requests hearing

BNB PLUS CORP.

Nasdaq notified APDN on May 30, 2025 that bid price closed below $1.00 for 32 consecutive business days, violating Listing Rule 5550(a)(2).
APDN executed a 1-for-15 reverse stock split on June 2, 2025 to address deficiency, but is ineligible for a compliance period due to prior reverse splits.
Company timely requested a hearing before Nasdaq Hearings Panel on June 6, 2025, which stays any suspension or delisting pending outcome.
No assurance that the Panel will grant continued listing; shares remain at risk of delisting.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

BNB PLUS CORP. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A), 5810(c)(3)(A)(iv)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A), 5810(c)(3)(A)(iv)

Exact text from the filing

May 30, 2025 (the “Notification Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) that the Company no longer satisfies the $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of thirty (30) consecutive business days (colle

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

BNB PLUS CORP. filing history →

Source: SEC EDGAR

accession 0001104659-25-057222

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.